We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Stockbroker tips from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Berenberg maintains 'buy' rating on Conduit Holdings

Thu 29 January 2026 11:44

(Sharecast News) - Berenberg reiterated its 'buy' rating on multi-line reinsurer Conduit Holdings on Thursday, stating the group's was a bneficiary of Bermuda's new Tax Credit Act.

RBC Capital lowers target price on C&C Group

Thu 29 January 2026 11:24

(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on alcoholic drinks manufacturer C&C Group from 160p to 130p on Thursday, stating headwinds had delayed the firm's recovery.

Broker tips: Energean, Kooth

Wed 28 January 2026 14:09

(Sharecast News) - Analysts at Berenberg lowered their target price on Energean from 850p to 780p as it updated its model for the company's FY25 trading update.

Canaccord Genuity lowers target price on Kooth

Wed 28 January 2026 12:51

(Sharecast News) - Canaccord Genuity lowered its target price on mental health services provider Kooth from 430p to 330p on Wednesday, but said the stock still represents a "buying opportunity".

Berenberg lowers target price on Energean following FY25 update

Wed 28 January 2026 09:46

(Sharecast News) - Analysts at Berenberg lowered their target price on Energean from 850p to 780p as it updated its model for the company's FY25 trading update,

Broker tips: Zotefoams, Burberry, AstraZeneca, GSK

Tue 27 January 2026 15:19

(Sharecast News) - Analysts at Berenberg hiked their target price on polymer foams manufacturer Zotefoams from 540p to 590p on Tuesday after the group's 22 January trading update revealed that both full-year revenue and adjusted pre-tax profits were expec

Citi starts AstraZeneca at 'buy', takes 'neutral' stance on GSK

Tue 27 January 2026 11:36

(Sharecast News) - Analysts at Citi initiated coverage of AstraZeneca and GSK on Tuesday, taking a bullish stance on the former but a more cautious view on the latter.

Barclays upgrades Burberry to 'overweight' after 'reassuring' Q3

Tue 27 January 2026 11:20

(Sharecast News) - Barclays upgraded Burberry on Tuesday to 'overweight' from 'equalweight' and lifted the price target to 1,450p from 1,340p following a "reassuring" third-quarter update, as it said the turnaround strategy was working.

Berenberg raises target price on Zotefoams

Tue 27 January 2026 09:44

(Sharecast News) - Analysts at Berenberg hiked their target price on polymer foams manufacturer Zotefoams from 540p to 590p on Tuesday after the group's 22 January trading update revealed that both full-year revenue and adjusted pre-tax profits were expec

Broker tips: 3i Group, Greencore

Mon 26 January 2026 13:58

(Sharecast News) - RBC Capital Markets downgraded 3i Group on Monday to 'underperform' from 'sector perform' and cut its price target on the stock to 3,000p from 3,250p as it said the valuation was still "on the full side".